Gallium-68 PSMA ([68Ga]Ga-PSMA) has had much traction recently in its utility in primary staging of high-grade prostate cancer, detection of biochemical recurrence, planning patients for radioligand therapy (130, 131). This evidence concerns the gene FOLH1 and prostate carcinoma.